0.697
Retractable Technologies Inc stock is traded at $0.697, with a volume of 10,717.
It is up +1.01% in the last 24 hours and down -3.19% over the past month.
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety medical products for the healthcare industry in the United States and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, and allergy antigen syringes; autodisable syringes; IV catheters; blood collection tube holders; and blood collection sets, as well as Patient Safe products, including syringes and Luer caps. The company also develops EasyPoint needles. In addition, it is developing retractable needles and syringes, glass syringes, dental syringes, and IV catheter introducers. Retractable Technologies, Inc. serves healthcare providers, such as acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, long-term care facilities, veterans administration facilities, military organizations, public health facilities, and prisons. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was founded in 1994 and is headquartered in Little Elm, Texas.
See More
Previous Close:
$0.69
Open:
$0.69
24h Volume:
10,717
Relative Volume:
0.40
Market Cap:
$20.87M
Revenue:
$37.15M
Net Income/Loss:
$-6.29M
P/E Ratio:
-3.2002
EPS:
-0.2178
Net Cash Flow:
$-7.41M
1W Performance:
-0.40%
1M Performance:
-3.19%
6M Performance:
+1.38%
1Y Performance:
-18.95%
Retractable Technologies Inc Stock (RVP) Company Profile
Name
Retractable Technologies Inc
Sector
Industry
Phone
972-294-1010
Address
511 Lobo Lane, Little Elm, TX
Compare RVP vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
RVP
Retractable Technologies Inc
|
0.697 | 20.95M | 37.15M | -6.29M | -7.41M | -0.2178 |
|
ISRG
Intuitive Surgical Inc
|
391.95 | 138.47B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
176.80 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
218.89 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
35.61 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
63.76 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
Retractable Technologies Inc Stock (RVP) Latest News
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - Yahoo Finance
HealthEquity’s board now has 11 directors, nine independent, after Moody’s finance chief joined. - Stock Titan
At 1:30 p.m. ET, HEALWELL AI's president is set to present to investors in Toronto. - Stock Titan
Vaccine Reconstitution Injection Syringes Market to Accelerate on Immunization Push, Driving Growth Through 2035 - IndexBox
A Sept. 30 fireside chat with Mineralys management will stream live at noon ET. - Stock Titan
Disposable Syringes Market to Reach USD 17,026.2 Million by 2035 Amid Rising Demand for Safe Drug Administration - industrytoday.co.uk
Safety-Engineered Syringe Shields Market To 2035: Regulatory Mandates Fuel 6-8% CAGRNews and Statistics - IndexBox
Retractable Needle Safety Mechanisms Market To 2035: Safety Mandates Drive GrowthNews and Statistics - IndexBox
Needle Safety Guard Shield Market Forecast to 2035: Growth Accelerates on Rising Biopsy and Vaccination Volumes - IndexBox
RUBI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
FARO Should I Buy - Intellectia AI
FARO Technical Analysis & Stock Price Forecast - Intellectia AI
SCPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Breaking News about Lument Finance Trust, Inc. Common Stock (NYSE:LFT) - FinancialContent
MasterCraft Guides to Up to $32 Million Adjusted EBITDA for Transition Period - minichart.com.sg
RVP Q3 2023 Earnings: $0.14 Per-Share Loss and Flat Stock Reaction Signal Uncertain OutlookPositive Surprise Momentum - dars.gov.et
Rest-Of-Europe Blood Collection Devices Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
Top Envirotech Vehicles (AZIO) Competitors 2026 - marketbeat.com
Retractable Technologies, Inc. Supports Senator Blackburn's ONSHORE Manufacturing Act - marketscreener.com
A proposed bill would offer tax breaks to make more medical supplies in the U.S. - Stock Titan
Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE Manufacturing Act - Yahoo Finance
Stock Market News for Sep 3, 2026 - Stock Titan
Syringe Tip Covers Market Outlook to 2035 - IndexBox
TELA Bio Announces $17 Million Annual Cost Reduction and CFO Change Amid Restructuring - Kalkine Media
Retractable Technologies Inc. (RVP) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Retractable Technologies Inc. (RVP) Key Financial Ratios – Valuation, Profitability & More - Value Research
Retractable Technologies (RVP) Edges Up 1.14% to $0.73, Holding Above Key SupportStock News - dars.gov.et
Retractable (RVP): Stays Close to Unchanged at $0.73 in the Available Record; Current Setup: $0.69 and $0.77 Define the Nearby Reference LevelsCTA Positioning - dars.gov.et
Should I Buy RVP? RVP 2026 AnalysisIntellectia AI™ - Intellectia AI
RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes - Barchart.com
Retractable Technologies Inc (RVP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Retractable Technologies’ operating loss hits USD 5.1M in Q2 2026 - Medical Buyer
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026 - marketscreener.com
Sterilizing Needle and Cannula Market to Reach 250 Index by 2035 on Biopharma Capacity Build-Out - IndexBox
Retractable Technologies Q2 EPS $0.09; Sales Fall 31% YoY - scanx.trade
Retractable Technologies: Q2 Earnings Snapshot - AOL.com
Retractable Technologies Reports $6.4M Equity-Sale Gain in Q2 - Stock Titan
Retractable Technologies (RVP) swings to Q2 profit despite revenue drop and tariffs - Stock Titan
Retractable Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Vaccine Administration Market to Reach US$ 12.4 Billion by 2033 at 9.2% CAGR - openPR.com
Retractable Technologies (RVP) Consolidates at $0.68 Amid Narrow Trading RangeLow Vol Factor - vinanet.vn
Australia Blood Collection Devices Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
Retractable Technologies Inc (RVP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Luer-Slip Syringe Tips Market Growth Driven by Clinical Diagnostics Through 2035News and Statistics - IndexBox
Sterile Fill Needles Market Growth to 2035 Driven by Biopharma Manufacturing ExpansionNews and Statistics - IndexBox
Retractable Technologies Inc (RVP) Stock News Today - TradingKey
Disposable Syringes Market: USD 24.94 Billion by 2031 as Safety-Engineered Devices & Rising Injection Volumes Accelerate Market Expansion, Says Mordor Intelligence - PR Newswire UK
Retractable Technologies (RVP) Slides to $0.66 as Support at $0.63 Comes into FocusElliott Wave Count - dars.gov.et
RVP Q3 2023 Earnings: Loss of $0.14 Per Share and 1.49% Stock Decline Highlight Challenging QuarterLow Growth Earnings - vinanet.vn
RVP Q3 2023 Earnings: Reports $0.14 Per Share Net Loss as Stock Declines 1.49Earnings Trend Analysis - dars.gov.et
Retractable Technologies Inc Stock (RVP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Retractable Technologies Inc Stock (RVP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SHAW THOMAS J | PRESIDENT AND CEO |
Nov 11 '25 |
Buy |
0.81 |
100 |
81 |
15,825,491 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Nov 05 '25 |
Buy |
0.83 |
7,500 |
6,195 |
15,825,391 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 30 '25 |
Buy |
0.86 |
15,000 |
12,915 |
15,817,891 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 28 '25 |
Buy |
0.92 |
35,000 |
32,028 |
15,802,891 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 27 '25 |
Buy |
0.94 |
34,506 |
32,522 |
15,767,891 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 23 '25 |
Buy |
0.95 |
356 |
339 |
15,733,385 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 22 '25 |
Buy |
0.96 |
10,000 |
9,600 |
15,733,029 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 14 '25 |
Buy |
0.93 |
14,204 |
13,147 |
15,723,029 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 08 '25 |
Buy |
0.92 |
30,000 |
27,699 |
15,708,825 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):